*  Richard Pratley on Anticipated Visit to the ADA Convention
In part 5, the conclusion of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his anticipated visit to the ADA convention.
  http://www.diabetesincontrol.com/richard-pratley-part-5-ada-2017-and-final-thoughts/
*  High Blood Sugar Linked To Aging And Disease
Advanced glycation end products And Antioxidants Is it possible that by eating too many metabolically active dense carbohydrates, you are much more likely
  http://www.diabetesincontrol.com/high-blood-sugar-linked-to-aging-and-disease/
*  ADA: Linagliptin Has Similar Efficacy to Glimepiride but Improved Cardiovascular Safety over 2 Years in Patients with Type 2...
Type 2 diabetes mellitus (T2DM) often requires combination therapy to maintain glycemic control. Adding a sulfonylurea to metformin therapy improves glycemic control, but can cause hypoglycemia and weight gain. This 2-yr double-blind trial investigated the long-term efficacy and safety of adding linagliptin or
  http://www.diabetesincontrol.com/ada-linagliptin-has-similar-efficacy-to-glimepiride-but-improved-cardiovascular-safety-over-2-years-in-patients-with-type-2-diabetes-inadequately-controlled-on-metformin-glp/
*  Leveraging Weight Loss in the Treatment of Type 2 Diabetes 2012 Part 1 of 4
In this week's set of Homerun Slides, we begin a four part series on how weight gain affects the overall health of our overweight and obese type 2
  http://www.diabetesincontrol.com/leveraging-weight-loss-type-2-diabetes-2012-part-1-of-4/
*  Richard Pratley on Overweight and Obesity Among Patients with Type 1 Diabetes.
In part 1 of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his work with diabetes patients and the growing epidemic of overweight and obesity among patients with type 1 diabetes.
  http://www.diabetesincontrol.com/richard-pratley-part-1-obesity-and-diabetes/
*  Production Assistant, Diabetes In Control, Author at Diabetes In Control. A free weekly diabetes newsletter for Medical...
It was a challenge to develop a computer model that could account for plasma dynamics in a compact but accurate package. The model was the simplest representation we could devise, which was based upon known physiology, and which could accurately describe moment-by-moment plasma dynamics. The model continues to thrive in that it continues to be the basis for a large number of clinical investigations (∼50 per year) as well as a robust literature related to its mathematical and computer characteristics Read More » ...
  http://www.diabetesincontrol.com/author/mdennis/page/33/
*  Outcomes of Self-monitoring of Blood Glucose in Type 2 Diabetes
Effect of frequent, self-monitoring of blood glucose may not be significant.... In this randomized controlled trial, researchers assessed whether
  http://www.diabetesincontrol.com/outcomes-of-self-monitoring-of-blood-glucose-in-type-2-diabetes/
*  Curbing Atrial Fibrillation with Weight Loss in Obese People
Australian researchers found a higher odds of eliminating symptoms of atrial fibrillation in obese patients who lost at least 10% of their body weight without undergoing surgery or medication than in those who failed to lose weight. The findings were presented at the American College of Cardiology meeting. -- Journal
  http://www.diabetesincontrol.com/curbing-atrial-fibrillation-with-weight-loss-in-obese-people/
*  Survey Says: Your Thoughts in 2017
In 2017, we offered weekly survey questions on topics ranging from standard tests, to new drugs, to opinions on CGMs, to personal exercise habits - and you answered. Here are the survey questions that drew the most response this year.
  http://www.diabetesincontrol.com/survey-says-thoughts-2017/
*  Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals
OSA epidemiology and risk factors: The prevalence of OSA varies considerably between studies, mainly due to differences in the population studied, study designs, and the method and criteria used to diagnose OSA. A prevalence of 4% in men and 2% in women has traditionally been quoted in many populations. The prevalence from three well-conducted studies with similar design from Wisconsin, Pennsylvania, and Spain showed an OSA prevalence of 17-26% in men and 9-28% in women and a prevalence of 9-14% and 2-7% for men and women with moderate to severe OSA. These studies used a two-stage sampling design which allows some degree of estimate of the "self-selection" bias which is usually a significant problem in OSA studies.. Read More » ...
  http://www.diabetesincontrol.com/?option=com_content&task=view&id=14245&Itemid=8
*  Find Me Gluten Free
JATX Tech, LLC iOS and Android Find Me Gluten Free uses GPS to locate chain restaurants nearby that offer a gluten-free selection. The key feature of this app is the GPS map function and an extensive library of menus, allowing the user to view available gluten-free options before travelling to a
  http://www.diabetesincontrol.com/find-me-gluten-free/
*  Low Carb Recipes. Chapter 7 - Part 2
The Diabetes Diet Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 2 of Chapter 7 Low Carb Recipes Here are a couple of lunch dishes: Too Be Continued in
  http://www.diabetesincontrol.com/low-carb-breakfast-recipes-chapter-7-part-2/
*  Endocrinologists Would Prescribe Bydureon for 20 Percent of Patients
Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed. Decision Resources announced the results of a survey of US endocrinologists who said they would prescribe Bydureon to 20% of their patients taking into consideration the
  http://www.diabetesincontrol.com/endocrinologists-would-prescribe-bydureon-for-20-percent-of-patients/
*  AACE: New Recommendations for Treatment of Prediabetes
New recommendations include: specific instructions for lifestyle intervention, and that pharmacotherapy be started at an A1c of six percent. It is estimate
  http://www.diabetesincontrol.com/aace-new-recommendations-for-treatment-of-prediabetes/
*  Editor's Note, DCMS #189: Ink-a Dinka Don't
Years ago there was a famous singer, actor, and comedian, Jimmy Durante, who would often start or end a joke with the phrase 'ink-a dinka doo.'
  http://www.diabetesincontrol.com/editors-note-dcms-189-ink-a-dinka-dont/
*  Using The One-Hour Postload Glucose Can Predict Future Diabetes
One-Hour Postload Glucose test: 12-year community-based cohort study investigated whether 1-h glucose concentration could be better indicator of diagnosis.
  http://www.diabetesincontrol.com/using-the-one-hour-postload-glucose-can-predict-future-diabetes/
*  Insulin Pump with Low Glucose Detection Now Approved
FDA approves the first US insulin pump with low glucose suspend feature.... Medtronic, maker of several products for diabetic patients, recently rece
  http://www.diabetesincontrol.com/insulin-pump-with-low-glucose-detection-now-approved/
*  Obesity Diagnosis May Depend on Medical Professionals Weight
The study findings indicate that medical professionals with normal BMI more frequently reported discussing weight loss with patients than overweight or
  http://www.diabetesincontrol.com/obesity-diagnosis-may-depend-on-medical-professionals-weight/
*  ADA 2017 - Diabetes In Control
Dr. Linda Siminerio RN, PhD is a Professor of Medicine at the University of Pittsburgh and Executive Director of the University of Pittsburgh Diabetes Institute. Dr. Siminerio has organized 44 diabetes self-management education programs throughout western Pennsylvania and for the U.S. military at Wilford Hall Medical Center at the Lackland Air Force Base in Texas. Dr. Siminerio's primary research topics include diabetes education, diabetes translation into community interventions, pediatric diabetes care and education, and the psychosocial and behavioral aspects of diabetes. Read More » ...
  http://www.diabetesincontrol.com/resources/videos-diabetes-education/ada-2017/page/24/
*  KEEP BUT DO NOT DISPLAY - Diabetes In Control
St. Petersburg Times, Dec 7, 2003 TheraSense Files Premarket Approval Application for Freestyle Navigator(TM) Continuous Glucose Monitor- The PMA filing follows recently presented clinical data on Navigator that included results of home-use trials involving 102 subjects at 7 clinical sites. FreeStyle Navigator is a continuous glucose monitor designed to replace …. Read More » ...
  http://www.diabetesincontrol.com/admin-use-only/page/129/
*  Type 1 Diabetics Stop Insulin Injections After Risky Experiment
Risky Brazil Experiment Enables Type I Diabetics to Live Without Insulin, Other Medicines Thirteen young diabetics in Brazil have ditched their insulin shots and need no other medication thanks to a risky, but promising treatment with their own stem cells -- apparently the first time such a feat has been
  http://www.diabetesincontrol.com/type-1-diabetics-stop-insulin-injections-after-risky-experiment/
*  Obesity Fueling a New Hybrid Diabetes: Double Diabetes or Type 1 & 1/2
Dubbed 'double diabetes' by some and 'diabetes one-and-a-half' by others, the combination of types 1 and 2 diabetes symptoms confounds doctors attempting to accurately diagnose and treat patients. Can it increase the risk for complications? 'We don't really know how prevalent this is,' said Francine
  http://www.diabetesincontrol.com/obesity-fueling-a-new-hybrid-diabetes-double-diabetes-or-type-1-12/